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Atrial	fibrillation	is	the	most	common	clinical	cardiac	arrhythmia.	It	is	often	initiated	by	ectopic	beats	aris-
ing	from	the	pulmonary	veins	and	atrium,	but	the	source	and	mechanism	of	these	beats	remains	unclear.	The	
melanin	synthesis	enzyme	dopachrome	tautomerase	(DCT)	is	involved	in	intracellular	calcium	and	reactive	
species	regulation	in	melanocytes.	Given	that	dysregulation	of	intracellular	calcium	and	reactive	species	has	
been	described	in	patients	with	atrial	fibrillation,	we	investigated	the	role	of	DCT	in	this	process.	Here,	we	
characterize	a	unique	DCT-expressing	cell	population	within	murine	and	human	hearts	that	populated	the	
pulmonary	veins,	atria,	and	atrioventricular	canal.	Expression	profiling	demonstrated	that	this	population	
expressed	adrenergic	and	muscarinic	receptors	and	displayed	transcriptional	profiles	distinct	from	dermal	
melanocytes.	Adult	mice	lacking	DCT	displayed	normal	cardiac	development	but	an	increased	susceptibility	
to	atrial	arrhythmias.	Cultured	primary	cardiac	melanocyte-like	cells	were	excitable,	and	those	lacking	DCT	
displayed	prolonged	repolarization	with	early	afterdepolarizations.	Furthermore,	mice	with	mutations	in	the	
tyrosine	kinase	receptor	Kit	lacked	cardiac	melanocyte-like	cells	and	did	not	develop	atrial	arrhythmias	in	the	
absence	of	DCT.	These	data	suggest	that	dysfunction	of	melanocyte-like	cells	in	the	atrium	and	pulmonary	
veins	may	contribute	to	atrial	arrhythmias.
Introduction
Atrial fibrillation (AF) is the most common cardiac arrhythmia 
and is associated with significant morbidity (1–4). Most individu-
als with AF have underlying cardiac disease, but approximately 
30%–45% with paroxysmal AF and 20%–25% with persistent AF 
are younger patients with no cardiac abnormalities (5, 6). Hais-
saguerre et al. identified ectopic beats arising from the pulmo-
nary veins (PVs) as initiators or arrhythmogenic triggers of AF 
(7) which led to PV isolation as an effective, empiric therapy for 
drug-refractory AF. However, PV isolation is associated with com-
plications and risks, including PV reconnection, which reduces its 
efficacy (8–10). On the other hand, pharmacologic anti-arrhyth-
mic therapy for AF is often ineffective and associated with bur-
densome side effects (11–13).
While most investigations to date have focused on the contribu-
tion of PV myocytes to AF triggers, some evidence supports the 
existence of nonmyocardial cells within PVs, which may also con-
tribute to these triggers. Recently, interstitial Cajal-like cells have 
been identified within human PVs (14, 15).	However, the direct 
contribution of such cells to atrial arrhythmogenesis has not been 
demonstrated. Still, the implications of identifying a unique cell 
population that may contribute to atrial arrhythmias are signifi-
cant, as they may unmask a previously unknown source or mecha-
nism of arrhythmogenesis. In addition to descriptions of new cell 
types that may contribute to atrial arrhythmias, emerging evidence 
supports the contribution of atrial ectopy outside the thoracic 
veins to atrial arrhythmias (16, 17). Since atrial myocytes do not 
possess the same cellular electrophysiological properties as those 
found in PV myocytes, the theories proposed to explain the initia-
tion of PV ectopy are unlikely to account for extrapulmonary vein 
foci. Therefore, the existence of a distinct cell population that may 
contribute to atrial triggers from the PVs and extrapulmonary foci 
may help explain this apparent inconsistency.
Pigmented cells within the murine heart have been observed pre-
viously (18–21), though their function remains unknown. Inter-
estingly, dermal melanocytes and melanoma lines do express volt-
age-dependent currents (22, 23) and under conditions of increased 
oxidative stress some ionic currents are modified to promote cel-
lular excitability (24–26). In the skin, reactive intermediaries such 
as 5,6-dihydroxyindole (DHI) (27) are formed in the pheomelanin 
synthesis pathway. On the other hand, 5,6-dihydroxyindole-2-car-
boxylic acid (DHICA), which is thought to be less reactive than 
DHI, is formed in the eumelanin synthesis pathway, diminish-
ing the formation of reactive species (28). The melanin synthe-
sis enzyme dopachrome tautomerase (Dct) contributes to, but 
is not required for, melanin synthesis in dermal melanocytes by 
catalyzing the conversion of L-dopachrome to DHICA (29). In the 
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absence of Dct, there is decreased DHICA formation with concom-
itant DHI build up, which promotes the accumulation of reactive 
species (30, 31). Furthermore, Dct is important for intracellular 
calcium regulation; in fact, eumelanin binds calcium with an affin-
ity similar to calmodulin (32). Given that dysregulation of calcium 
and reactive species have been described in patients with AF (33), 
and the fact that Dct is involved in both calcium handling and 
reactive species generation, we sought to investigate the role of Dct 
and Dct-expressing cells in atrial arrhythmogenesis.
In the present study, we characterized Dct-expressing cells in 
the murine and human heart. Single-cell transcriptional profil-
ing showed that murine Dct-expressing cells in the heart more 
closely resemble atrial myocytes than dermal melanocytes. Mice 
lacking functional DCT retained melanocyte-like cells in the heart 
and were susceptible to atrial arrhythmias. By contrast, animals 
lacking melanocyte-like cells in the heart failed to demonstrate 
atrial arrhythmias, even if they also lacked Dct. Isolated cardiac 
melanocytes were excitable, with similar action potentials to atrial 
myocytes. However, in the absence of Dct, cardiac melanocytes 
displayed prolonged repolarization with early afterdepolariza-
tions and frequent calcium oscillations. Dct-positive cells in the 
murine atrium expressed adrenergic and muscarinic receptors 
and appeared to be innervated by autonomic nerves. Furthermore, 
treatment with muscarinic agonists resulted in fewer atrial arrhyth-
mia episodes in mice that lacked cardiac melanocyte-like cells than 
in littermates that retained cardiac melanocytes, suggesting that 
the presence of these cells promotes arrhythmogenesis. β-Adren-
ergic antagonists reduced atrial arrhythmias to a larger extent in 
mice with cardiac melanocytes, further demonstrating the impor-
tance of autonomic regulation of this cell population. Treatment 
of mice lacking Dct with antioxidants also significantly reduced 
atrial arrhythmias. These findings support a potential connection 
between Dct-expressing cells, the clinical syndrome of atrial ectopy 
initiating AF, autonomic dysregulation, and oxidative stress.
Results
Melanocyte-like cells are present in the murine and human PVs. We 
examined Dct expression in the heart by in situ hybridization, 
immunohistochemistry, and β-galactosidase staining in Dct-
LacZ mice (34) during murine embryogenesis and found strong 
Table 1
Distribution of Dct-expressing cells in P1 murine heart
Location	 Cell	number
Right atrium 425.3 ± 62.4
Left atrium 202.8 ± 55.0
Atrial septum 287.1 ± 75.5
Tricuspid annulus 894.2 ± 24.2
Mitral annulus 805.7 ± 86.3
Pulmonary valve 152.0 ± 44.6
Aortic valve 315.3 ± 20.2
PVs 266.6 ± 49.6
Ventricular myocardium 0
Total cell count 3,359.1 ± 84.7
Data are expressed as mean ± SD. Five hearts were sectioned and 
stained with an antibody against Dct.
Figure 1
Dct-expressing cells populate the heart. (A) X-gal stain-
ing of an E11.5 Dct-LacZ embryo demonstrated stain-
ing near pharyngeal arches (arrows), developing telen-
cephalon (T), and eye (E). (B) In situ hybridization of 
an E13.5 heart showed Dct expression (filled arrows) 
around a PV os (open arrowhead). (C) X-gal staining 
of an E13.5 Dct-LacZ heart in the posterior atrium and 
endocardial cushions. (D) X-gal staining of an E13.5 
Dct-LacZ heart in the septal leaflet valve primordia. 
Inset scale bar: 500 μm. (E) Immunofluorescence 
of Dct-positive cells (arrowheads) within the PVs. (F) 
X-gal staining in an E16.5 Dct-LacZ heart in the poste-
rior atrium (arrows). (G and H) X-gal staining in a Dct-
LacZ heart along the right atrial septum above the valve 
annulus at E17.5 (G; inset scale bar: 500 μm) and P1 
(H). (I) Immunofluorescence showed Dct-positive cells 
lining the SAN artery epithelium, the tricuspid valve, and 
the mitral valve. Inset (scale bar: 100 μm) shows boxed 
region. (J) Immunofluorescence of Dct-positive cells 
(arrow) in the tricuspid valve of a 15-day-old mouse. 
(K) Adult mouse (P60) resulting from crossing a Dct-
Cre+/– and R26R mouse demonstrated LacZ-positive 
cells (arrows) within the PVs and atria. (L) Dct-positive 
cells detected by immunofluorescence (arrows) on the 
endothelium of explanted human PV. Scale bars: 500 
μm (A–C, F, H, I, K); 100 μm (D, E, G); and 50 μm (J 
and L). LA, left atrium; Ao, aorta; PA, pulmonary artery; 
MV, mitral valve; TV, tricuspid valve; RA, right atrium; 
IVC, inferior vena cava; FO, foramen ovale; CS, coro-
nary sinus; SAN, sinoatrial node; VV, venous valve.
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expression in mid- to late-gestation hearts. Through E11.5, 
Dct-expressing cells were not identified in the heart, unlike pre-
viously described cardiac neural crest cells (Figure 1A) (35, 36). 
By E13.5, Dct-expressing cells were evident in the PVs, posterior 
atrium, and septal leaflets of the atrioventricular valves (Figure 
1, B–D). Between E14.5 and E16.5, Dct-positive cells were pres-
ent in the posterior atrium and atrial-PV anastomoses (Figure 1, 
E and F). By late gestation, Dct-expressing cells were prominent 
near the region of, but not specifically within, the compact atrio-
ventricular node (Figure 1, G–I), as well as around the region of 
the sinoatrial node (Figure 1I and Table 1). Thereafter, punctate 
expression of these cells within the heart and PVs was retained 
from birth to adulthood (Figure 1, I–K). We also identified Dct-
positive cells within the PVs of all 8 human postmortem samples 
examined (Figure 1L). Interestingly, pigmentation of these cells 
in humans was not evident. The absence of tyrosinase related 
protein-1 (Tyrp-1; data not shown) may explain why these cells 
are not pigmented, since Tyrp-1, but not Dct, denotes melanocyte 
differentiation with pigment expression.
Dct-positive cells express melanoblast markers but not those of cardiomyo-
cytes, fibroblasts, or neurons. In the mouse embryo, Dct-positive cells 
in the heart expressed markers of the melanoblast lineage, includ-
ing Sox10, Mitf, and tyrosinase (Tyr). At a later time point (E17.5), 
Tyrp1 and Pax3 were also expressed (Figure 2, A–O). These cells 
appeared to be morphologically distinct from cardiomyocytes (Fig-
ure 2, A, J, and M). Ultrastructural analysis of Dct-expressing cells 
showed numerous caveolae along the plasma membrane and a sub-
set of cells that contained mature melanosomes (Figure 3, A–D). 
Figure 2
Dct-expressing cells in the atrium express markers of 
the melanoblast lineage. (A–O) Sections from E17.5 
hearts co-stained by immunofluorescence for Dct (A, 
D, G, J, and M), Sox10 (B), Mitf (E), Tyr (H), Pax3 
(K), and Tyrp-1 (N), respectively. Merged images for 
Dct and each individual marker are shown (C, F, I, L, 
and O). (P–R) Section through the anterior leaflet of 
the pulmonary valve of an E17.5 Wnt1Cre, R26R heart 
stained for Dct (arrows, P) and β-galactosidase (open 
arrows, Q). No overlap of staining was seen in merge 
(R). Original magnification, ×400 (A–O); ×100 (P–R).
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Expression of fibronectin, neurofilament, tyrosine hydroxylase, 
α-actin, MF20, smooth muscle actin, and Islet 1 was not observed 
in Dct-expressing cells distinguishing these cells from fibroblasts, 
neurons, myocytes, smooth muscle, and secondary heart field cells, 
respectively (Supplemental Figure 1; supplemental material avail-
able online with this article; doi:10.1172/JCI39109DS1) (37).
Murine cardiac melanocyte-like cells are distinct from other cardiac 
neural crest lineages. Most, but not all, melanocytes are derived 
from multipotent neural crest precursors that arise in the dor-
sal neural tube, where they express Wnt1 and Pax3 (38, 39). To 
fate-map neural crest cells, we crossed Wnt1Cre (36) transgenic 
and Pax3Cre knockin (40) mice with R26R LacZ reporter mice (41) 
and examined E16.5 (Pax3Cre and Wnt1Cre) and P1 (Wnt1Cre) 
hearts with antibodies that recognize DCT and β-galactosidase 
(Figure 2, P–R). Surprisingly, fate-mapped Pax3Cre and Wnt1Cre 
cells did not express Dct. Moreover, we have examined hundreds 
of mid-gestation embryonic hearts derived from Wnt1/Pax3Cre, 
R26R crosses and we have never observed LacZ-expressing cells in 
the atrioventricular canal where Dct expression was prominent, 
although Wnt1/Pax3Cre-derived cells contribute to septation of 
the outflow tract and the great vessels (our unpublished observa-
tions). However, by E17.5, Dct-expressing cells began to co-express 
Pax3 (Figure 2, J–L). Based on these findings, we concluded that 
Dct-expressing cells in the heart represent a distinct population 
from Wnt1/Pax3 expressing precursors that orchestrate outflow 
tract septation, although they activate Pax3 expression during late 
gestation. Thus, these cells either may arise from what we believe 
is a newly identified subpopulation of neural crest precursors that 
fail to express Wnt1 or Pax3 at early time points and for which we 
do not presently know of an available genetic marker, or they may 
arise from a non-neural crest-derived cell lineage.
Transcriptional profiling suggests cardiac melanocyte-like cells are 
distinct from dermal melanocytes and atrial myocytes. We performed 
single-cell isolation and transcriptional profiling of Dct-express-
ing cells in the heart in order to define a gene expression signature 
and for comparison to related cell types. In parallel, we profiled 
atrial myocytes and dermal melanocytes (Figure 4) (42). Interest-
ingly, cluster analysis of global gene expression suggested Dct-
expressing cells are more closely related to atrial myocytes than 
to dermal melanocytes. Both cell types express similar calcium-
handling proteins (such as phospholamban and ryanodine recep-
tor, type 2) and some voltage-gated ion channels (for example the 
pore-forming subunit of L-type calcium channels and cardiac 
voltage-dependent sodium channels; Supplemental Tables 1–3). 
However, Dct-positive cells in the heart lacked significant expres-
sion of some signature cardiomyocyte genes, such as cardiac actin 
and troponins (Table 2 and Supplemental Tables 1–3). Thus, Dct-
expressing cells in the heart can be molecularly distinguished 
from atrial myocytes and dermal melanocytes.
Murine melanocyte-like cells are present in the heart despite the absence 
of Dct. To examine the function of Dct-expressing cells in the 
heart, we utilized Dct-Cre mice that produce no functional DCT 
(43). Dct+/– mice appear phenotypically normal, while Dct–/– mice 
are viable and display reduced pigmentation. We generated Dct–/– 
mice that also carried the Dct-LacZ transgene to examine expres-
sion of β-galactosidase in Dct+/+ and Dct–/– embryos. Dct-LacZ was 
expressed normally in the hearts of Dct–/– embryos, suggesting that 
Dct expression is not required for migration or survival of melano-
cyte-like cells in the heart (Figure 5).
Dct–/– mice are susceptible to induced and spontaneous atrial arrhythmias 
in the absence of structural cardiac abnormalities. The location of Dct-
expressing cells in the PVs, atrium, and atrioventricular annulus 
prompted us to investigate the contribution of Dct to cardiac elec-
trical activity and conduction. We performed invasive electrophysi-
ologic studies in mature Dct–/– and Dct+/– littermates. Atrial burst 
pacing induced 27 episodes of atrial arrhythmia in 9 of 11 Dct–/– 
mice (Figure 6A and Table 3). These episodes lasted 781 ± 417 mil-
liseconds (range: 119–1529 ms), while the same protocol induced 
2 episodes in 1 of 12 control mice (172 and 540 ms). In addition, 
spontaneous episodes of atrial tachycardia were recorded in 2 of 4 
conscious Dct–/– mice with implantable ambulatory monitors, while 
control littermates demonstrated no such activity (Figure 6B). Addi-
Figure 3
Ultrastructural analysis of Dct-expressing cardiac cells. (A) Low-power 
and (B) high-power transmission electron microscopy demonstrated 
association between 4 Dct-LacZ–expressing cells. White arrowheads 
indicate electron-dense X-gal precipitate in the cytoplasm and peri-
nuclear area. N denotes the same nucleus in both A and B (scale 
bars: 2 μm and 1 μm, respectively). (C and D) High-power transmis-
sion electron microscopy of 2 Dct-expressing cells. Cells in C con-
tained no melanosomes, while Cell2 in D contained type III and type 
IV melanosomes. Cell1 contained X-gal precipitate (white arrowhead). 
Black arrowheads in C and D denote caveolae. Scale bars: 500 nm. 
(E and F) High-power transmission electron microscopy of mitochon-
dria in the atrial myocardium of a Dct+/– mouse (E) and a Dct–/– mouse 
(F). Note that some mitochondria appear slightly enlarged, with less 
densely packed and disorganized matrices in the absence of Dct. 
Scale bars: 500 nm. N, nucleus; M, mitochondria; III, type 3 melano-
some; IV, type 4 melanosome.
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tional invasive electrophysiological analysis revealed no differences 
in conduction intervals or refractory periods (Table 3). Consistent 
with these analyses, the surface ECG revealed no difference in base-
line intervals or electrogram morphology (Figure 6C and Supple-
mental Table 4). Therefore, Dct–/– mice show increased susceptibil-
ity to atrial arrhythmogenesis, unaccompanied by any other cardiac 
electrophysiological alteration.
To examine whether the atrial arrhythmias observed in the 
absence of Dct were related to alterations in atrial or ventricular 
structure, echocardiographic and histological analysis were per-
formed in Dct–/– and Dct+/– mice. However, no structural or func-
tional abnormalities were found in Dct–/– mice compared with 
control littermates (Figure 6D and Supplemental Table 5). In 
addition, myocardial interstitial fibrosis and alterations in myo-
cyte structure were not observed in Dct–/– mice compared with con-
trol littermates (data not shown). Therefore, it is unlikely that the 
atrial arrhythmias observed in Dct–/– mice resulted from primary 
derangements in atrial structure or function.
Presence of Dct-expressing cells in the heart is Kit dependent. To examine 
how Dct-expressing cells promote arrhythmogenesis, we utilized a 
Figure 4
Hierarchical clustering and ANOVA of single-cell gene expression data. Each column represents expression data from a single cell from 1 of 3 
classes: cardiac Dct-expressing cell (pink), atrial myocyte (orange), or dermal Dct-expressing cell (green). Expression analysis was performed on 
those transcripts that had 2-fold expression above or below the mean in each cell class. The cluster analysis depicted at top was subsequently 
performed after ANOVA demonstrated significant expression differences between each of the 3 cell classes. Fold changes are represented 
graphically, with red tiles demonstrating greater than 2-fold expression above the median, yellow representing median expression, and blue 
demonstrating expression 2-fold below the median. See Supplemental Table 3 for the identity of the genes analyzed. Dendrograms show cor-
relation of gene expression profiles between samples. The length of the dendrogram branches connecting pairs of nodes represents the level 
of correlation between samples. Note that each cell class segregates to a discrete node, with the cardiac Dct-expressing cells sharing greater 
correlation with atrial myocytes than dermal Dct-expressing cells, confirming that each cellular class has a distinct signature.
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mouse model lacking Dct-expressing cells in the heart. Mice with 
mutations in the tyrosine kinase receptor Kit (W/+, Wv/+, and 
W/Wv) possess pigmentation defects secondary to impaired migra-
tion of some, but not all, neural crest–derived cell lines (44, 45). 
Therefore, we examined hearts from Kit mutant mice to determine 
whether these mutations affect migration of Dct-expressing cells. 
Gross and microscopic examination of hearts from W/Wv mice 
and wild-type littermates confirmed the absence of Dct-express-
ing cells within mutant hearts (Figure 7). Furthermore, invasive 
electrophysiology studies in W/Wv mice and Dct–/–,W/Wv litter-
mates demonstrated no differences in atrial refractory periods 
or induced atrial arrhythmias in W/Wv versus Dct–/–, W/Wv mice 
(Dct–/–, W/Wv: 5 episodes, 178 ± 112 ms; W/Wv: 2 episodes, 99 ms, 
125 ms; P = NS; Table 3). Thus, the lack of atrial arrhythmias, in 
the absence of Dct-expressing cells 
on a Dct–/– background, further 
implicates these cells as a source of 
atrial arrhythmogenesis.
Murine cardiac Dct-positive cells 
express adrenergic and muscarinic 
receptors and interact with autonomic 
nerves. Given the robust evidence 
linking alterations in autonomic 
efflux to the onset of PV ectopy 
and clinical AF (46–48), we sought 
evidence that Dct-expressing cells 
within the heart may be regulated 
by the autonomic nervous system. 
In the skin, dermal melanocytes are 
influenced by both sympathetic and 
parasympathetic input (49). Dct-
positive cells express β1-adrenergic, 
α1-adrenergic, and M3-muscarinic 
receptors (Figure 8, A–I), but not 
M1-muscarinic, M2-muscarinic, or 
β2-adrenergic receptors (data not 
shown). Additionally, costaining 
against tyrosine hydroxylase and 
DCT revealed sympathetic nerve 
terminals abutting Dct-positive 
cells in the murine atrium (Figure 
8, J–L). Costaining against choline acetyltransferase and DCT simi-
larly revealed cholinergic nerves abutting Dct-positive cells (Figure 
8, M–O). In addition, murine Dct-positive cells themselves express 
choline acetyltransferase. These data suggest a model whereby Dct-
expressing cells in the murine atrium respond to autonomic efflux, 
which could contribute to arrhythmias.
Cardiac melanocytes influence autonomic effects upon atrial arrhythmo-
genesis. The fact that murine cardiac melanocytes express musca-
rinic and adrenergic receptors, and that they appear to interact with 
autonomic nerves, suggests these cells are influenced by the auto-
nomic nervous system. To obtain direct evidence that autonomic 
influences upon cardiac melanocytes contribute to atrial arrhyth-
mias, we performed invasive electrophysiology studies in wild-type 
mice and Kit mutant mice that lacked cardiac melanocytes. Since 
Table 2
Expression of selected ion channel and calcium-handling transcripts in cardiac Dct-expressing cells
Symbol	 GenBank	ID	 Description	 Fold	change
Pln AK002622 Phospholamban 5.93
Cacna1c NM_009781 Calcium channel, voltage-dependent, L-type, α1C subunit 2.49
Atp2b1 BI080417 ATPase, Ca++ transporting, plasma membrane 1 2.67
Ryr2 NM_023868 Ryanodine receptor 2, cardiac 2.31
Gjc1 NM_008122 Gap junction protein, γ1 2.30
Atp2a2 AA245637 ATPase, Ca++ transporting, cardiac muscle 2 1.88
Clic4 BB814844 Chloride intracellular channel 4 1.82
Vdac2 BC003731 Voltage-dependent anion channel 2 1.74
Cav3 NM_007617 Caveolin 3 1.60
Kctd18 BB257241 Potassium channel tetramerization domain 1.58
Atp1a1 BC025618 ATPase, Na+/K+ transporting, α1 polypeptide 1.53
Kcmf1 BG071725 Potassium channel modulatory factor 1 1.52
Clic4 BB398988 Chloride intracellular channel 4 1.51
Scn5a BB516098 Sodium channel, voltage-gated, type V, α 1.14
Kcnk3 BF467278 Potassium channel, subfamily K, member 3 1.11
Kcnj1 NM_019659 Potassium inwardly rectifying channel, subfamily J, member 1 1.08
Single-cell transcriptional profiling was performed on atrial and dermal primary cultures of Dct+/– mice. RNA 
was harvested from 5 different samples of cardiac Dct-expressing cells, dermal Dct-expressing cells, and 
atrial myocytes. Expression data were normalized to the mean of all transcripts assays for in each cell type 
and displayed as fold change above the norm of the transcripts assayed in atrial myocytes. The GeneSpring 
analysis program was used to identify those genes categorized as ion channel transcripts. The above table 
represents the identity of ion channel transcripts with greater than 1.0-fold expression above the norm within 
the ion channel category.
Figure 5
Cardiac melanocyte-like cells persist in the heart in the absence of 
Dct. Hearts derived from Dct+/– (A and C) or Dct–/– (B and D) mice that 
also carried the Dct-LacZ transgene were stained with X-gal. Anterior 
(A and B) and posterior (C and D) views are shown, with labeled cells 
seen in a similar pattern in Dct+/– and Dct–/– (filled arrows). Insets in C 
and D show the posterior atrial wall, where labeled cells are evident 
(arrows). Original magnification, ×40 (A–D); ×100 (insets).
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Figure 6
Dct–/– mice have inducible and spontaneous atrial arrhythmias with normal cardiac structure and function. (A) Recordings from ECG lead I (I), 
right atrium, and right ventricle show AF induced by burst stimulation (S) in a Dct–/– animal. Irregularly irregular intervals between ventricular (v) 
beats are denoted. Sinus beats are shown on termination of the episode with normal atrial (a) and ventricular electrograms. Inset demonstrates 
magnified view of denoted area. (B) Real-time telemetry recorded in an awake Dct–/– mouse with an implantable monitor demonstrates sponta-
neous AF characterized by abrupt onset of a rapid irregularly irregular rhythm with no discrete p-waves. The inset shows a faster time scale of a 
few beats of sinus rhythm (arrows), followed by the onset of AF. (C) Surface ECGs from Dct–/– and Dct+/– littermate mice demonstrating normal 
ECG morphologies. (D) Two-dimensional echocardiographic imaging from a 4-chamber view demonstrating no qualitative difference in atrial 
dimensions during atrial systole or atrial diastole in Dct–/– and Dct+/+ littermate mice. Scale bar: 2 mm.
Downloaded from http://www.jci.org on January 11, 2016.   http://dx.doi.org/10.1172/JCI39109
research article
	 The	Journal	of	Clinical	Investigation   http://www.jci.org   Volume 119   Number 11   November 2009 3427
Kit mutant mice do not develop atrial arrhythmias (despite the 
presence or absence of Dct), we provoked atrial arrhythmia in these 
mice and their wild-type littermates using the long-acting musca-
rinic agonist carbamyl choline. Muscarinic stimulation promotes 
sustained atrial arrhythmias in mice with normal hearts (50). Car-
bamyl choline shortens atrial refractory periods through its action 
upon acetylcholine-activated inward rectifier currents in atrial myo-
cytes, which induces the substrate to sustain atrial arrhythmias. 
These studies revealed that W/Wv mice had approximately 40% 
fewer induced atrial arrhythmias episodes than their wild-type lit-
termates (W/Wv: 36 episodes in 6 of 8 mice lasting 27.8 ± 2.9 s; wild-
type: 64 episodes in 7 of 8 mice lasting 29.1 ± 3.5 s; Table 4). There 
were no differences in the effects of these drugs upon conduction 
intervals or refractory periods between these 2 groups (Table 4). 
Administration of the β-adrenergic antagonist propranolol, in 
the presence of carbamyl choline, was about 25% more effective in 
reducing the number of induced atrial arrhythmia episodes in wild-
type mice compared with W/Wv littermates (wild-type: 38 episodes 
in 6 of 8 mice, down from 64 episodes [41% reduction], lasting 
24.1 ± 3.2 s; W/Wv: 30 episodes in 7 of 8 mice, down from 36 epi-
sodes [17% reduction], lasting 23.6 ± 2.6 s; Table 5). These findings 
suggest that muscarinic and adrenergic regulation of cardiac mela-
nocytes may affect the development of atrial arrhythmias.
Oxidant scavengers reduce atrial arrhythmias in Dct–/– mice. Dct has 
antioxidant effects in the skin (30), and reactive oxygen species 
can modify ion currents in cardiomyocytes (24–26). Therefore, 
we sought to determine whether the loss of Dct promotes atrial 
arrhythmias, at least in part, by affecting reactive oxygen species. 
We performed invasive electrophysiol-
ogy studies in Dct–/– mice treated with 
the oxidant scavenger tempol for 1 week 
and compared them with Dct–/– mice 
treated with vehicle. Dct–/– mice treated 
with tempol had approximately 68% 
fewer atrial arrhythmia episodes com-
pared with vehicle-treated controls (tem-
pol: 7 episodes in 3 of 10 mice lasting 
957 ± 671 ms; vehicle: 22 episodes in 7 
of 10 mice lasting 877 ± 325 ms; Table 6). 
There were no significant changes in 
conduction intervals or refractory peri-
ods induced by tempol (Table 6). These 
findings suggest that reactive oxygen 
species contribute to atrial arrhythmia 
triggers in the absence of Dct.
Dct–/– cardiac melanocyte-like cells display 
prolonged repolarization and triggered activ-
ity. The lack of structural abnormalities 
or alterations in atrial refractoriness sug-
gests that loss of Dct induces arrhyth-
mogenesis by promoting triggered 
activity. Dermal melanocytes express volt-
age-dependent ion channels (22); there-
fore, we hypothesized that Dct-positive 
cells in the heart are excitable and can act 
as arrhythmogenic triggers. To test this 
hypothesis, we performed whole-cell cur-
rent clamp recordings (51) from primary 
cultures. These studies revealed action 
potential prolongation in Dct–/– cardiac 
melanocytes (Figure 9, A and B, and Table 7), while Dct+/– cells and 
atrial myocytes of either genotype had comparable action potential 
duration (Table 7). Such profound prolonged repolarization likely 
promotes elevations in diastolic calcium (52) and afterdepolariza-
tions. Consistent with these findings, we observed afterdepolariza-
tions arising from phase 3 of spontaneous action potentials in Dct–/– 
cardiac melanocytes, while afterdepolarizations were not observed 
in Dct+/– cells (Figure 9C). In addition, fluorescent calcium imaging 
revealed that Dct–/– cardiac melanocytes generate frequent calcium 
oscillations, while Dct+/– cells demonstrate no such activity (0/8 con-
trol, 5/8 Dct–/–; P = 0.026, Fisher’s exact test; Figure 10). Finally, to 
determine whether Dct-expressing cells in the heart form electrical 
connections with neighboring cardiomyocytes, we performed Luci-
fer yellow dye transfer experiments. These studies clearly demon-
strated functional gap junctions between Dct-expressing cells and 
neighboring cardiomyocytes (Figure 11, A–C). Supporting these 
findings, the gap junction protein Gjc1 (connexin 45) mRNA was 
significantly increased in our single-cell mRNA expression profil-
ing of cardiac melanocytes, and we confirmed connexin 45 expres-
sion (53) in Dct-expressing cells by immunohistochemistry (Table 2, 
Supplemental Table 2, and Figure 11, D–F). These data suggest that 
downregulation of Dct promotes cellular excitability in murine car-
diac melanocytes. Furthermore, we have evidence to support the 
ability of Dct-expressing cells to form functional gap junctions.
Discussion
We describe a population of melanocyte-like cells in the heart and 
PVs of mice and humans that appear to contribute to atrial arrhyth-
Table 3
Baseline invasive electrophysiology intervals
Parameter	 Dct–/–	(n	=	11)	 Dct+/–	(n	=	12)	 W/Wv	(n	=	10)	 Dct–/–,W/Wv	(n	=	10)
AH (ms) 34.7 ± 4.9 30.8 ± 6.4 33.0 ± 5.1 35.1 ± 5.8
Hd (ms) 4.1 ± 1.3 4.3 ± 1.1 4.0 ± 1.4 4.2 ± 1.0
HV (ms) 11.3 ± 2.3 11.1 ± 2.7 10.8 ± 2.4 11.0 ± 2.1
AVI (ms) 49.0 ± 6.5 49.1 ± 6.8 48.7 ± 6.4 50.3 ± 6.7
SNRT120 (ms) 208.0 ± 51.6 230.1 ± 74.2 224.6 ± 69.8	 238.2 ± 67.6
SNRT100 (ms) 200.3 ± 68.3 220.8 ± 76.7 209.4. ± 58.9 222.7 ± 66.1
AVWCL (ms) 94.5 ± 6.9 95.8 ± 7.6 99.4 ± 7.4 100 ± 8.2
AVERP120 (ms) 68.6 ± 7.4 67.5 ± 9.9 70.8. ± 8.5 71.4 ± 8.8
AERP120 (ms) 39.5 ± 7.3 41.3 ± 5.3 43.8 ± 5.7 42.7 ± 4.6
AERP100 (ms) 38.2 ± 5.6 40.0 ± 5.8 44.6 ± 6.2 43.9 ± 4.6
VERP120 (ms) 33.2 ± 11.5 34.2 ± 10.8 35.8 ± 9.5 36.5 ± 8.9
VERP100 (ms) 35.9 ± 9.1 32.9 ± 11.6 36.0 ± 10.1 36.8 ± 9.7
Episodes of AT 27A,B,C 2D 2D 5D
Episodes of VT 7 10 8 9
ATCL (ms) 32.2 ± 7.8 76.5 46.9 38.4 ± 6.7
AT duration (ms) 781 ± 417 356 112 178 ± 112A
Age (d) 56.7 ± 4.8 58.4 ± 6.4 59.7 ± 5.8 62.0 ± 7.9
Weight (g) 21.2 ± 3.7 21.4 ± 2.8 22.0 ± 2.4 21.8 ± 2.6
AP < 0.05 compared with Dct+/–; BP < 0.05 compared with W/Wv; CP < 0.05 compared with Dct–/–,W/Wv; 
DP < 0.05 compared with Dct–/–. AH, atrio-hisian interval; Hd, His duration; HV, hisioventricular interval; 
AVI, atrioventricular interval; SNRT120, sinus node recovery time at drive train of 120 ms; AVWCL, 
atrioventricular Wenckebach block cycle length; AVERP120, atrioventricular effective refractory period 
at drive train of 120 ms; AERP120, atrial effective refractory period at drive train of 120 ms; VERP120, 
ventricular effective refractory period at drive train of 120 ms; AT, atrial tachycardia; VT, ventricular 
tachycardia; AT CL, atrial tachycardia cycle length. Data are presented as the mean ± SD and tests 
of statistical difference were computed using 1-way ANOVA followed by Tukey post-hoc analysis. The 
numbers of arrhythmic episodes were assumed to have a Poisson distribution, and the Kolmogorov-
Smirnov test was used to assess statistical significance between groups.
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mogenesis. These cells display several features that implicate them 
as arrhythmogenic triggers. First, Dct-expressing cells reside within 
anatomic regions known for triggering clinical atrial arrhythmias. 
Second, they display cardiomyocyte-like excitability and calcium 
handling characteristics. Third, these cells express adrenergic and 
muscarinic receptors, appear to interact with autonomic nerves, 
and can be influenced by autonomic effluxes. Finally, atrial arrhyth-
mias cannot be elicited in mice that lack Dct-expressing cells.
In the murine heart, Dct-positive cells express adrenergic and 
muscarinic receptors, and we have documented sympathetic and 
parasympathetic nerves that likely innervate these cells. In patients 
with clinical AF, a rise in sympathetic output precedes the onset of 
AF by 10–15 minutes, followed by a dramatic rise in vagal output 
just prior to the onset of arrhythmia (46–48). Since Dct activity is 
increased by protein kinase A phosphorylation in dermal melano-
cytes (54), it is possible that Dct activity in cardiac melanocytes 
is downregulated by vagal output just before the onset of clinical 
AF. Downregulation of Dct activity in cardiac melanocyte-like cells 
may then result in higher oxidative stress that could modulate ion 
channels and calcium-handling proteins, thereby increasing cell 
excitability. Such increased excitability may then result in ectopy 
from cardiac melanocytes and trigger atrial arrhythmogenesis.
Along these lines, most cases of paroxysmal AF appear to be ini-
tiated by ectopy arising from the PVs, and Dct-positive cells are 
consistently expressed within murine and human PVs. In addition 
to their location around the PVs, we see a significant number of 
Dct-positive cells within the atrium, coronary sinus, and atrio-
ventricular annulus. In the time since Haissaguerre et al. identi-
fied PV ectopy as triggers of AF (7), other studies have implicated 
atrial sites outside the PVs as a source of AF triggers (17) or ecto-
pic atrial arrhythmias (55, 56). Sites that commonly contribute 
to atrial arrhythmogenesis correspond to the regions where we 
observe Dct-positive cells: the PVs, the posterior atrial wall, the 
atrioventricular annulus, and the coronary sinus. Therefore, the 
correlation between anatomical sites associated with clinical atrial 
arrhythmia initiation and the location of Dct-expressing cells is 
consistent with the suggestion that these cells may act as a source 
of arrhythmogenic triggers.
Figure 7
Dermal and cardiac pigmentation in W/Wv mice. Shown are representative hearts from wild-type (A–D), Wv/+ (E–H), W/+ (I–L), and W/Wv (M–P) 
littermates. The wild-type mouse demonstrated normal dermal pigmentation (A and B) and the presence of cardiac pigmentation (C and D). Tri-
cuspid valve at low (C) and high power (D); black arrow denotes pigmented cells in a valve leaflet. Wv/+, W/+, and W/Wv mice showed abnormal 
dermal pigmentation (E, F, I, J, M, and N) as well as absence of pigmented cells within the valves (G, H, K, L, O, and P). Immunohistochemical 
staining with an anti-Dct antibody similarly showed labeling within wild-type mouse hearts, but cardiac staining was absent in Wv/+, W/+, and 
W/Wv mice (not shown). Original magnification, ×40 (C, G, K, and O); ×200 (D, H, L, and P).
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It is intriguing to speculate why Dct-expressing cells exist in the 
heart. In skin, the synthesis of melanin evolved to protect against 
damage from ionizing sunlight. In this setting, the enzymatic 
intermediaries of melanin synthesis are known to modulate cal-
cium and reactive species (32). Consistent with this observation, 
cells with melanin synthesis enzymes in the PVs and heart may 
also exist to buffer calcium and reactive species. However, during 
pathologic processes, free radical and calcium-binding affinity 
may be altered or overwhelmed in these cells, transforming them 
into initiators of triggered activity and cardiac arrhythmias. The 
fact that tempol reduces atrial arrhythmia inducibility in Dct–/– 
mice suggests that reactive oxygen species contribute to cardiac 
melanocyte excitability and implies that these cells may also be 
involved with maintaining the normal balance of oxidative species 
in the myocardium.
In conclusion, Dct-expressing cells within the PVs and atrium 
appear to contribute to atrial arrhythmias. This interpretation is 
supported by the presence of induced and spontaneous arrhythmia 
Figure 8
Dct-expressing cells coexpress adren-
ergic and muscarinic receptors. Immuno-
histochemistry within the adult mouse 
atrium using an antibody to Dct demon-
strated Dct-positive cells with charac-
teristic morphology (A, D, G, J, and M). 
Sections were co-stained with antibodies 
to β1-adrenergic receptor (β1R; B), α1-
adrenergic receptor (α1R; E), muscarinic 
receptor subtype 3 (M3R; H), tyrosine 
hydroxylase (T-OH; K), and choline acet-
yltransferase (ChAT; N). Merged images 
of Dct and each respective antibody are 
shown, demonstrating coexpression 
of Dct with β1R (C), α1R (F), and M3R 
(I) receptors (arrowheads). Addition-
ally, presumptive nerve terminals that 
express tyrosine hydroxylase (L) and 
choline acetyltransferase (O) were seen 
in close proximity to Dct-expressing cells 
(arrows). Scale bars: 20 μm.
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in mice containing cardiac melanocytes that lack functional Dct, 
as well as by the absence of arrhythmia in mouse models that lack 
cardiac melanocytes (Kit mutants). Characteristics of these cells 
further add support to their role in arrhythmogenesis: since they 
reside in locations that clinically originate abnormal electrical activ-
ity, they are excitable and electrically coupled to neighboring myo-
cytes, and this activity can be regulated through changes in auto-
nomic tone. While there are currently no data that directly correlate 
Dct-positive cells or Dct activity to clinical atrial arrhythmias, the 
studies presented here suggest that further investigations into the 
role of Dct and cardiac melanocytes in clinical 
atrial arrhythmias are warranted. Such studies 
may not only enhance our mechanistic under-
standing of some forms of atrial arrhythmias, 
but may also lead to effective therapies for AF 
by selectively targeting these cells.
Methods
Animals. The creation of Dct-Cre (43), Dct-LacZ trans-
genic (57), Wnt1Cre transgenic (36), and Pax3Cre 
knockin mice (40) has been previously described. 
R26R Gt(ROSA)26Sor (41) and the Z/EG transgenic 
mice (ACTB-βgeo/GFP)21Lbe (58) were obtained 
from The Jackson Laboratory. All mice used in 
this study were inbred 5 generations or more on a 
C57BL/6 background. Wnt1Cre, Pax3Cre knockin, and 
Dct-Cre knockin mice were each crossed with R26R 
β-galactosidase reporter mice. All protocols con-
formed to the guidelines established by the Associa-
tion for the Assessment and Accreditation of Labora-
tory Animal Care and were approved by the University 
of Pennsylvania Animal Care and Use Committees.
β-Galactosidase activity staining. Whole-mount and 
tissue specimens were stained for β-galactosidase 
activity using previously described protocols (59, 
60). Briefly, hearts from fetal mice E10.5 and older 
were dissected from embryos, placed in PBS, rinsed 
of blood, fixed in 2% PFA for 30 minutes, and incu-
bated in X-gal solution at 55°C overnight. Wild-type 
littermate controls, without the Dct-LacZ transgene, 
were processed side by side in the same manner. 
In situ hybridization.	In situ hybridization was per-
formed as previously described (61) using a Dct anti-
sense probe corresponding to GenBank NM_010024 
as described in refs. 45, 60, 61.
Immunohistochemistry. Immunohistochemistry 
was performed on paraffin-embedded tissue fixed 
in 2% paraformaldehyde. Explanted human PVs 
were provided for these studies by J. Cooper and 
P. Sanchez (University of Pennsylvania). Antigen 
was exposed using Bull’s Eye reagent (Biocare 
Medical) and heated in a pressure cooker. Anti-
bodies utilized were mouse monoclonal anti-Pax3 
(1:800; Developmental Studies Hybridoma Bank), 
monoclonal mouse anti–α-actin (1:20; Dako), rab-
bit polyclonal anti–β-galactosidase (1:200; Cortex), 
rabbit anti-tyrosine hydroxylase (1:100; Chemi-
con), mouse monoclonal anti-neurofilament (2H3) 
(1:25; Developmental Studies Hybridoma Bank), 
mouse monoclonal anti-Mitf (1:5; Novocastra), 
rabbit polyclonal anti-Sox10 (1:200; Chemicon), goat polyclonal anti-Dct 
(1:100), goat anti-Tyrp1 (1:100), goat anti-Tyr (1:100; Santa Cruz Biotech-
nology Inc.), rabbit anti–connexin 40 (1:20; Zymed), rabbit anti–connexin 
45 (1:100; provided by R. Gourdie, Medical University of South Carolina, 
Charleston, South Carolina, USA), mouse monoclonal anti-Isl1 (1:50; 
Developmental Studies Hybridoma Bank), rabbit anti-fibronectin (1:100; 
Novus), rabbit anti–β1-adrenergic receptor (1:100; Sigma-Aldrich), rab-
bit anti–M3-mucarinic receptor (1:50; Santa Cruz Biotechnology Inc.), 
rabbit anti–α1-adrenergic receptor (1:100; Sigma-Aldrich), and rabbit 
anti-choline acetyltransferase (1:100; Millipore). Secondary antibodies 
Table 5
Electrophysiology effects of β-adrenergic inhibition with cardiac melanocytes
Parameter	 Wild-type	mice	(n	=	8)	 W/Wv	mice	(n	=	8)
	 Carbachol	 Propranolol		 Carbachol	 Propranolol	
	 	 +	carbachol	 	 +	carbachol
AH (ms) 43.0 ± 5.2 46.8 ± 6.4 42.1 ± 4.4 45.3 ± 5.8
Hd (ms) 4.1 ± 1.0 4.3 ± 1.1 3.8 ± 1.3 4.2 ± 1.0
HV (ms) 11.2 ± 2.4 11.1 ± 2.7 11.4 ± 2.7 11.0 ± 2.1
AVI (ms) 58.0 ± 7.1 60.1 ± 6.8 57.3 ± 6.3 60.3 ± 6.7
SNRT120 (ms) 340.4 ± 67.2 363.8 ± 74.2 364.6 ± 67.6	 379.2 ± 75.7
SNRT100 (ms) 360.9 ± 76.7 395.7 ± 68.2 383.2 ± 66.1 409.0 ± 72.0
AVWCL (ms) 108.1 ± 6.6A,B 126.8 ± 7.6C,D 114.3 ± 7.5A,B 129.2 ± 8.2C,D
AVERP120 (ms) 83.7 ± 7.9 92.5 ± 9.9 85.9 ± 7.0 95.4 ± 8.8
AERP120 (ms) 24.6 ± 7.0A,B 35.3 ± 5.3C,D 26.2 ± 7.5A,B 36.7 ± 4.0C,D
AERP100 (ms) 25.0 ± 8.1A,B 36.0 ± 5.6C,D 27.1 ± 7.8A,B 34.9 ± 4.6C,D
Episodes of AT 64A,B,D 38B,C,D 36A,B,C 30A,C,D
ATCL (ms) 27.7 ± 8.7 35.6 ± 7.5 29.0 ± 8.2 38.4 ± 7.9
AT duration (s) 29.7 ± 3.5A,B 24.1 ± 3.2C,D 27.8 ± 2.9A,B 23.6 ± 2.6C,D
Age (d) 54.9 ± 5.2 54.9 ± 5.2 56.2 ± 5.4 56.2 ± 5.4
Weight (g) 22.8 ± 2.9 22.8 ± 2.9 21.6 ± 2.7 21.6 ± 2.7
AP < 0.05 compared with wild-type propranolol plus carbachol; BP < 0.05 compared with W/Wv 
propranolol plus carbachol; CP < 0.05 compared with wild-type carbachol; DP < 0.05 compared 
with W/Wv carbachol. Data analysis was performed as described in Table 3.
Table 4
Electrophysiology effects of muscarinic stimulation with cardiac melanocytes
Parameter	 Wild-type	mice	(n	=	8)	 W/Wv	mice	(n	=	8)
	 Baseline	 Carbachol	 Baseline	 Carbachol
AH (ms) 32.6 ± 4.1A,B 43.0 ± 5.2C,D 31.7 ± 4.5A,B 42.1 ± 4.4C,D
Hd (ms) 3.9 ± 1.2 4.1 ± 1.0 4.0 ± 1.2 3.8 ± 1.3
HV (ms) 10.9 ± 2.2 11.2 ± 2.4 11.0 ± 2.1 11.4 ± 2.7
AVI (ms) 47.7 ± 5.8A,B 58.0 ± 7.1C,D 46.5 ± 5.2A,B 57.3 ± 6.3C,D
SNRT120 (ms) 193.9 ± 49.8A,B 340.4 ± 67.2C,D 225.1 ± 69.8A,B	 364.7 ± 67.6C,D
SNRT100 (ms) 206.7 ± 55.0A,B 361.4 ± 76.7C,D 209.2 ± 58.9A,B 382.9 ± 66.1C,D
AVWCL (ms) 97.2 ± 7.2A,B 107.8 ± 6.6C,D 99.4 ± 7.4A,B	 114.1 ± 7.5C,D
AVERP120 (ms) 70.5 ± 7.9A,B 83.7 ± 7.9C,D 72.4. ± 6.9A,B 85.9 ± 7.0C,D
AERP120 (ms) 38.6 ± 6.8A,B 24.6 ± 7.0C,D 39.7 ± 5.6A,B 26.2 ± 7.5C,D
AERP100 (ms) 39.6 ± 6.4A,B 25.0 ± 8.1C,D 40.8 ± 5.2A,B 27.4 ± 7.8C,D
Episodes of AT 2A,B 64B,C,D 4 36A,C,D
ATCL (ms) 36.4 26.7 ± 8.7 35.5 ± 6.2 25.0 ± 8.2
AT duration (s) 0.19A,B 29.7 ± 3.5C,D 0.23 ± 0.15A,B 27.8 ± 2.9C,D
Age (d) 54.9 ± 5.2 54.9 ± 5.2 56.2 ± 5.4 56.2 ± 5.4
Weight (g) 22.8 ± 2.9 22.8 ± 2.9 21.6 ± 2.7 21.6 ± 2.7
AP < 0.05 compared with wild-type carbachol; BP < 0.05 compared with W/Wv carbachol;  
CP < 0.05 compared with wild-type; DP < 0.05 compared with W/Wv. Data analysis was per-
formed as described in Table 3.
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conjugated with fluorescent tags (Alexa Fluor; Molecular Probes) were 
used at a dilution of 1:250.
Invasive electrophysiology. Protocols for in vivo mouse electrophysiology 
studies have been previously described in detail (60, 62). Briefly, adult mice 
(8–10 weeks old) and age- and sex-matched control littermates were anes-
thetized with pentobarbital (33 mg/kg i.p.). Surface ECGs were obtained 
using 26-gauge needles placed s.c. under each limb. A right jugular venous 
cut-down was performed, and a 1.7-Fr octapolar electrode catheter (CIBer 
mouse EP; NuMed) was positioned in the right atrium and ventricle under 
intracardiac electrogram guidance. Rectal temperature was monitored and 
maintained at 34°C ± 1°C. Invasive studies were performed in 75 mice: 
11 Dct–/– and 12 Dct+/–; 8 W/Wv; 8 Dct–/–,W/Wv; and 10 Dct–/– treated with 
tempol (Sigma-Aldrich; 29 mM p.o. in drinking water with 4% sucrose for 
1 week); 10 Dct–/– mice treated with drinking water plus 4% sucrose (vehicle); 
and 8 W/Wv and 8 wild-type mice treated with carbachol (Sigma-Aldrich; 
20 μg/kg i.p.) and propranolol (Sigma-Aldrich; 20 mg/kg i.p.). Only atrial 
stimulation was performed during studies with carbachol and proprano-
lol. Intracardiac electrograms were recorded and displayed simultaneously 
with surface ECG leads on a multichannel oscilloscope (Bard Electro-
physiology) and stored on optical disks for off-line analysis. Programmed 
electrical stimulation was delivered using a digital stimulator (DTU-215A; 
Bloom Associates) following standard pacing protocols to assess atrial and 
ventricular conduction, refractoriness, and arrhythmia inducibility using 
up to 3 extrastimuli and burst pacing. Impulses were delivered at twice 
diastolic threshold with pulse duration of 1.0 ms. We defined an atrial 
arrhythmia as 3 or more atrial beats with a cycle length of 90% or less than 
the preceding sinus cycle length with a different P-wave morphology than 
sinus rhythm. Surface ECG intervals were measured in 6-limb leads by 2 
experienced, independent observers blinded to the animal’s genotype.
Ambulatory ECG monitoring. Miniature telemetry transmitter devices 
(Data Science International) were implanted as previously described (63). 
Once the mice fully recovered from the implantation procedure (after 
7 days), their cardiac ECGs were recorded during regular physical activity 
for 24 hours to detect any signs of spontaneous arrhythmia or AV conduc-
tion disturbances. Signals were stored on the hard drive of a Windows-
based PC for off-line analysis. We recorded electrograms from 4 Dct–/– mice 
as well as age- and sex-matched heterozygote littermates.
Ultrasound imaging and Doppler echocardiography. An Accuson ultrasound 
system with a 30-MHz transducer was used to scan Dct–/–, Kit mutant, and 
control littermate mice anesthetized with isoflurane (3% induction followed 
by 1%–2% maintenance dose) on a heating pad as previously described 
(64). ECG electrodes and a rectal probe were used to monitor heart rate 
(450–550 bpm) and body temperature (36°C–37°C), respectively. Hair was 
removed from the abdomen, and prewarmed ultrasound gel was applied. 
Two-dimensional, M-mode, color flow, and spectral Doppler imaging was 
then performed. Atrial and ventricular fractional shortening was calculated 
offline using analytic software (VisualSonics). The percentage shortening 
fraction was calculated from M-mode measurements using the leading edge 
method via the formula: %SF = [LVID(d) – LVID(s)] / LVID[d]), where %SF is 
percentage shortening fraction, LVID(d) is left ventricular internal diameter 
(diastole), and LVID(s) is left ventricular internal diameter (systole).
Monolayer preparation. This protocol is a modification of the method 
described by Freshney (65). Briefly, P0.5 to P1 hearts from Dct–/– or Dct+/– 
mice with the Z/EG transgene were dissected from pups, washed in PBS, 
splayed open, and incubated overnight (6–18 hours) in calcium-free HBSS, 
10 mM HEPES, 0.5% trypsin, and 0.54 mM EDTA at 4°C. The trypsin solu-
tion was then aspirated, and individual hearts were incubated at 37°C for 
30 minutes in 6-well dishes. Each heart was then transferred to a 15-ml tube 
and triturated with a medium bore transfer pipette 10–30 times in 5 ml cal-
cium-free HBSS with 10% horse serum, 5% FBS, 10 mM HEPES buffer, and 
1% penicillin/streptomycin. Cells were centrifuged at 680 g at 4°C. Pellets 
were then rinsed in 10 ml of calcium-free DMEM with 10% horse serum, 
5% FBS, and 1% penicillin/streptomycin and gently resuspended without 
aerating the solution. This solution was respun at 680 g at 4°C. The pellet 
was then gently resuspended in 3 ml Opti-MEM with 10% horse serum, 5% 
FBS, and 1% penicillin/streptomycin. The solution was transferred through 
a 70-μm strainer onto 25-mm glass coverslips pre-plated with laminin at 
10 μg/cm2. Cells were then incubated at 37°C in 5% CO2. After 48 hours, 
the solution was removed and replaced with Opti-MEM with 0.7% horse 
serum, 0.3% FBS, and 1% penicillin/streptomycin. Patch clamp and calci-
um imaging studies were performed on the second day after plating when 
monolayers beat spontaneously and reached 70%–80% confluence, since 
this was the time point at which GFP fluorescence appeared and cells were 
sufficiently dispersed to record from individually.
Cellular electrophysiology. Current clamp recordings were performed using 
the patch clamp technique in the whole-cell configuration described by 
Hamill et al. (51). Briefly, gigaohm seals were achieved using pipettes fash-
ioned from borosilicate glass (Harvard Apparatus) with resistances of 2–2.5 
MΩ after fire polishing. Recordings were obtained from neonatal cardio-
myocytes and Dct-expressing cells 2 days after dissociation. Action poten-
tials were recorded from spontaneously contracting cells or elicited using 
an Axopatch 200B amplifier by injecting 0.2–0.5 nA pulses at 1 Hz or 6 Hz 
with a 2-ms duration controlled by a Pentium 4–based computer running 
the pClamp program (version 9.2; Molecular Devices). Voltage recordings 
were filtered at 1–2 kHz and digitized at 25 kHz using the Digidata 1332A 
A/D converter (Molecular Devices). Only cells with resting potentials lower 
than –50 mV, seal resistances ≥ 500 MΩ, and access resistance less than 10 
MΩ were accepted for analysis. For current clamp recordings, pipette solu-
tion contained 110 mM/l KCl, 5 mM/l Na2-ATP, 11 mM/l EGTA, 10 mM/l 
HEPES, 1 mM/l CaCl2, 1 mM/l MgCl2, pH 7.3, with KOH, and bath solution 
contained 132 mM/l NaCl, 4.8 mM/l KCl, 10 mM/l HEPES, 2 mM/l CaCl2, 
1.2 mM/l MgCl2, pH 7.4, with NaOH.
Table 6
Electrophysiological effects of tempol in Dct–/– mice
Parameter	 Vehicle	(n	=	10)	 Tempol	(n	=	10)
AH (ms) 32.5 ± 5.3 33.1 ± 6.0
Hd (ms) 4.4 ± 1.4 4.1 ± 1.1
HV (ms) 11.5 ± 2.6 11.2 ± 1.8
AVI (ms) 49.0 ± 6.5 49.1 ± 6.8
SNRT120 (ms) 215 ± 54.8 227 ± 52.7
SNRT100 (ms) 187 ± 78.3 212 ± 66.4
AVWCL (ms) 96.7 ± 7.0 98.9 ± 7.6
AVERP120 (ms) 72.8 ± 9.2 76.2 ± 10.4
AERP120 (ms) 40.8 ± 6.3 43.6 ± 5.8
AERP100 (ms) 39.6 ± 4.8 42.0 ± 5.2
VERP120 (ms) 35.0 ± 10.7 36.4 ± 10.1
VERP100 (ms) 36.2 ± 8.7 34.7 ± 9.4
Episodes of AT 22 7A
Episodes VT 8 9
Mean ATCL (ms) 28.9 ± 12.8 27.2 ± 11.6
Mean AT duration (ms) 877 ± 325 957 ± 671
Age (d) 59.2 ± 5.7 60.5 ± 5.2
Weight (g) 22.9 ± 4.1 21.6 ± 3.8
AP < 0.05 compared with vehicle-treated group. Data are presented as 
mean ± SD, and tests of statistical difference were computed using the  
2-tailed Student’s t test. The numbers of arrhythmic episodes were 
assumed to have a Poisson distribution, and the Kolmogorov-Smirnov test 
was used to assess statistical significance between groups. Statistical sig-
nificance for mean AT duration was determined by the Mann-Whitney test.
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Calcium imaging. Changes in intracellular calcium concentration ([Ca2]i) 
were assessed using Fluo-4/AM (Invitrogen) as described previously (66). 
Prior to incubation with Fluo-4/AM, spontaneously beating cells adher-
ent to 25-mm glass coverslips were affixed to a chamber on the stage of 
an inverted microscope (model TE300; Nikon). Cells were excited with a 
Kr/Ar-ion laser at 488 nm to identify GFP-positive cells at an emission 
wavelength of 510 nm. These cells were placed in the center of the visual 
field, and the dish was subsequently incubated at room temperature in 
5 mM Fluo-4/AM for 30 minutes, followed by 10 minutes in dye-free medi-
um. Coverslips were maintained in a PDMI-2 open perfusion microincuba-
tor (Harvard Apparatus) at 37°C. Confocal imaging was performed using 
the Radiance 2000 imaging system (Bio-Rad Laboratories) equipped with 
a Kr/Ar-ion laser source at 488 nm excitation using a 
×60 oil objective. Images were collected using Laser-
Sharp software (Bio-Rad Laboratories) at 0.862 ms/
line for [Ca2]i changes. Cellular health was confirmed 
in parallel experiments through direct measurement 
of resting membrane potential (current clamp experi-
ments). Furthermore, current traces were performed 
on GFP-positive cells with uptake and cleavage of 
Fluo-4/AM ester and contiguous with adjacent myo-
cytes that beat spontaneously. Resultant line scans 
were analyzed using the Metamorph analysis soft-
ware (version 7; Molecular Devices).
Electron microscopy. The electron microscopy 
method has been previously published (67, 68). 
Briefly, we performed electron microscopy on hearts 
that labeled Dct-expressing cells with the Dct-LacZ 
transgene (57). Hearts were harvested from P1 pups and fixed with 0.5% 
glutaraldehyde for 10 minutes. After initial fixation, the sections were 
washed with PBS 3 times and subsequently placed in X-gal solution for 
4 hours. The results were monitored by microscopy. Hearts were then 
washed again with PBS 3 times for 5 minutes each, followed by fixation 
with 2.5% glutaraldehyde for 1 hour. The samples were placed in sodium 
cacodylate buffer and the X-gal–positive area dissected and postfixed with 
1% osmium tetroxide for 1 hour. Tissues were further washed with sodium 
cacodylate buffer, followed by en bloc stain with 1% uranyl acetate for 
1 hour in the dark. Tissues were then dehydrated with ethanol and infil-
trated with epoxy resin, and these specimens were polymerized at 68°C for 
48 hours. Semi-thin sections (1 micron) were cut to select the X-gal–posi-
Table 7
Action potential parameters
Parameter	 Cardiac	melanocytes	 Atrial	myocytes
	 Dct+/–	(n	=	7)	 Dct–/–	(n	=	7)	 Dct+/–	(n	=	8)	 Dct–/–	(n	=	8)
APD90 (ms) 17.0 ± 3.8A 75.5 ± 22.2B,C,D 15.2 ± 1.0A 14.6 ± 1.72A
APD50 (ms) 9.2 ± 4.0A 19.3 ± 8.0B,C,D 5.7 ± 1.0A 5.2 ± 1.5A
dV/dt (mV/ms) 37.8 ± 14.7 35.7 ± 12.0 30.1 ± 8.1 34.0 ± 8.7
Vr (mV) –59.3 ± 8.9 –65.7 ± 12.9 –61.1 ± 9.2 –62.3 ± 12.8
AP < 0.05 compared with Dct–/– melanocytes; BP < 0.05 compared with Dct+/– melanocytes; 
CP < 0.05 compared with Dct+/– myocytes; DP < 0.05 compared with Dct–/– myocytes. APD90, 
action potential duration at 90% repolarization; dV/dt, action potential upstroke rate of rise; Vr, 
resting membrane potential. Data are presented as the mean ± SD, and statistical significance 
was assessed using 1-way ANOVA followed by Tukey post-hoc analysis.
Figure 9
Dct–/– cardiac melanocytes demonstrate prolonged action potential duration and afterdepolarizations. (A) Current clamp recordings from cardiac 
Dct+/– and Dct–/– cells demonstrated increased action potential duration in the absence of Dct. Resting potential of the Dct+/– cell was –62 mV, 
while the Dct–/– cell had a resting potential of –60 mV. (B) Representative cardiac melanocyte from a Dct+/–, Z/EG mouse visualized by DIC and 
fluorescence (GFP). Scale bar: 10 μm. (C) Spontaneous action potential recordings from Dct–/– and Dct+/– cardiac melanocytes. Within the trace 
from the Dct–/– cell, note the presence of an early afterdepolarization (arrow) arising from phase 3 of the preceding action potential. The trace 
from a Dct+/– cell is included for comparison.
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tive areas for ultrathin sections. The sections, both unstained and stained 
with uranyl acetate/lead citrate, were analyzed using either a JEOL-1010 
or FEI Tecnai T-12 electron microscope.
Single-cell RNA isolation and analysis.	The method used is based upon previ-
ously described protocols with minor modifications (42). Briefly, primary 
culture of atrial myocytes, cardiac Dct-expressing cells, and dermal Dct-
expressing cells were prepared as outlined above. At least 5 cells of each 
type were harvested from at least 2 different litters. All preparations were 
handled under identical conditions and solutions. Two days after plating, 
coverslips were placed on a warmed microscope stage and Dct-expressing 
cells were identified by fluorescence excitation at 488 nm. Myocytes were 
identified by the absence of fluorescence and spontaneous contractions. 
A single cell was aspirated using a micropipette filled with 3% RNasin 
(Promega) in HBSS and placed in a microcentrifuge tube containing dNTPs 
(Amersham) 5X First Strand buffer (Invitrogen), dT-T7 oligo (Midland), 
and DTT (Invitrogen). The samples was incubated for 5 minutes at 70°C 
and then immediately placed on ice. The volume was brought up to 10.25 μl 
with DEPC-treated water. A mixture containing RNasin and Superscript 
III (Invitrogen) was then added and the sample incubated for 2 hours at 
50°C. The resulting RNA/DNA hybrid was denatured for 15 minutes at 
70°C and stored at –20°C. RNA concentration was determined by spectro-
photometer. Samples were concentrated as need by vacuum centrifugation 
to obtain 6 μg of RNA in 40 μl. RNA was hybridized to Affymetrix Mouse 
430 2.0 arrays without fragmentation and analyzed using GeneSpring soft-
ware (version 7.3.1; Agilent Technologies). Raw data were normalized to the 
median per gene to the fiftieth percentile per sample. Any data point below 
Figure 10
Dct–/– cardiac melanocytes display spontaneous calcium oscillations. (A–D) Representative cells from Dct+/–, Z/EG and Dct–/–, Z/EG hearts. A 
and C show DIC images; B and D show DIC images merged with fluorescent images demonstrating GFP-positive Dct-expressing cells. Mel, 
Dct-expressing cell; myo, atrial myocyte. Scale bars: 20 μm. (E and F) Representative linescans normalized to background from Dct+/– (E) and 
Dct–/– (F) preparations demonstrated calcium mobilization in the Dct-expressing cell (mel) as well as an adjacent myocyte (myo). (G–K) Graphs 
demonstrating normalized calcium flux in a Dct+/– melanocyte (G) and an adjacent myocyte (J), as well as from a Dct–/– melanocyte (H) and an 
adjacent myocyte (K). Note an oscillation following the fourth complex in H characterized by a rapid upstroke prior to full repolarization of the 
preceding complex. (I) Portions of the graph in H and K, denoted by the horizontal red bar, at a higher time resolution. Note that the upstroke of 
the oscillation in the melanocyte precedes calcium mobilization in the adjacent myocyte (vertical red bar). F/F0, measured fluorescence normal-
ized to peak fluorescence.
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0.01 was set equal to 0.01. ANOVA was then performed without assuming 
equal variance and a false discovery rate of 0.05, and then filtered using a 
threshold of greater than 1-fold change. Cluster analysis was also performed 
on normalized data using Pearson’s correlation coefficient.
Quantitative RT-PCR. Protocols for quantitative RT-PCR have been 
described previously (64), using SYBR Green according to the manu-
facturer’s protocol. Briefly, total RNA was isolated from single cardiac 
melanocytes and atrial myocytes as described above for single-cell RNA 
isolation, and 2 μg of total RNA was reverse transcribed using an oligo-
dT primer and the Super Script First-Strand Synthesis System (Invitro-
gen). PCR was performed with 5 μl of reverse-transcribed cDNA reaction 
mixture, 400 nmol/l of specific forward and reverse primers, and 1x SYBR 
Green PCR Master Mix (Applied Biosystems). Quantification of the reac-
tion product was performed using the MJ Research DNA Engine Opticon 
2 real-time detection system. The size of the amplicon for each PCR reac-
tion (see Supplemental Table 3) was verified by gel electrophoresis. PCR 
cycle conditions were 95°C for 10 minutes, followed by 40 cycles of dena-
turation at 95°C for 15 seconds and annealing and extension at 60°C for 
1 minute. Reactions were performed in triplicate with and without RT as 
controls. Cycle threshold values were converted to relative gene expres-
sion levels using the 2–ΔΔCt method. Primer pairs corresponding to each 
cDNA are listed in Supplemental Table 3.
Lucifer yellow dye transfer studies.	Lucifer yellow dye transfer dye studies 
were performed as described previously (69). Briefly, monolayers were 
prepared as described above. High-resistance pipettes (12–14 MΩ) were 
fashioned from borosilicate glass (Harvard Apparatus) and filled with 
250 μm lucifer yellow lithium salt (Invitrogen). Dct-expressing cells were 
identified by green fluorescence and photographed while the pipette in 
the cell attached patch configuration. The membrane was subsequently 
ruptured to create the whole-cell patch configuration, dye transfer was 
allowed to occur, and microphotographs were taken 
to verify dye transfer.
Statistics. All values are expressed as the mean ± SD. Dif-
ferences between 2 groups were analyzed using 2-tailed 
Student’s t test or, when not normally distributed, using 
a nonparametric Mann-Whitney U test. Differences in 
means among multiple data sets were analyzed using 
1- or 2-way ANOVA with treatment or genotype as the 
independent factors. When ANOVA showed significant 
differences, pairwise comparisons between means were 
tested using Tukey post-hoc analysis. When data were 
not normally distributed, ANOVA on ranks was used 
with the Kruskal-Wallis test, followed by pairwise com-
parison using the Dunn test. The numbers of arrhyth-
mic episodes were assumed to have a Poisson distribu-
tion, and the Kolmogorov-Smirnov test was used to 
assess statistical significance between groups. A P value 
less than 0.05 was considered significant in all analyses 
(SigmaStat Statistical Software; Jandel Scientific).
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Figure 11
Functional coupling of cardiac melanocytes with atrial myocytes and gap junction expres-
sion in cardiac melanocytes. (A–C) A lucifer dye transfer experiment demonstrated func-
tional coupling between a Dct-expressing cell and an adjacent atrial myocyte in culture. 
(A) A patch pipette containing 250 μM of lucifer yellow in the cell-attached configuration 
prior to membrane rupture (time 1). (B and C) Dct-expressing cardiac melanocyte in the 
whole-cell configuration after membrane rupture (time 2) visualized with fluorescence 
excited at 488 nm (B) and with both fluorescence and white light via Hoffman illumination 
(C). (D–F) Dct-positive cells in the atrium express connexin 45 (Cx45). Sections from an 
adult wild-type mouse atrium co-stained by immunofluorescence with Dct (D) and con-
nexin 45 (E). Dct-positive cells that coexpressed connexin 45 in the merge image (F) are 
indicated by arrowheads. Scale bar: 20 μm.
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